NU Skin Enterprises EV/EBIT NUS
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.
- Today, Oct 23, 2026
- 3.6×
- 10-year median
- 10.9×
- Against its 10-year history
- 3rd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 3.3× to 43.2×
- Peer median
- 14.4×
NU Skin Enterprises' EV/EBIT is 3.6× as of Oct 23, 2026.
That is below its ten-year median of 10.9×, lower than on 97% of days in the last ten years.
Over that time it ranged from 3.3× in Jul 2026 to 43.2× in Aug 2024.
The median for 10 healthcare stocks of a similar size is 14.4×.
EV/EBIT over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.6× | 3.3× | 18.1× |
| 2025 | 15.3× | 8.2× | 34.8× |
| 2024 | 8.7× | 8.5× | 43.2× |
| 2023 | 10.0× | 7.7× | 13.1× |
| 2022 | 12.2× | 7.2× | 12.2× |
| 2021 | 8.7× | 6.7× | 13.6× |
| 2020 | 12.3× | 3.8× | 13.3× |
| 2019 | 7.1× | 6.6× | 11.7× |
| 2018 | 10.5× | 10.0× | 16.6× |
| 2017 | 15.4× | 10.9× | 15.8× |
| 2016 | 10.8× | 5.8× | 18.3× |
| 2015 | 7.7× | 5.4× | 10.2× |
| 2014 | 6.0× | 4.6× | 17.2× |
| 2013 | 17.1× | 6.5× | 18.1× |
| 2012 | 5.9× | 5.8× | 17.2× |
| 2011 | 15.3× | 7.5× | 96.5× |
Against its peers
Companies in Healthcare nearest NU Skin Enterprises' size, closest first, today.
| Company | EV/EBIT |
|---|---|
| NUSNU Skin Enterprises | 3.6× |
| UTMDUtah Medical Products | 6.0× |
| ELMDElectromed | 14.4× |
| NATRNatures Sunshine Products | 5.2× |
| PLXProtalix BioTherapeutics | 7.5× |
| PDEXPro DEX | 16.0× |
| INFUInfuSystem | 22.4× |
| VMDViemed Healthcare | 16.3× |
| EMBCEmbecta | 6.7× |
| ARVNArvinas | n/m |
| NRCNRC Health | 38.8× |
| Peer median | 14.4× |
Where NU Skin Enterprises ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on NU Skin Enterprises
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.